Acro Biomedical (ACBM) EBITDA (2016 - 2026)
Acro Biomedical (ACBM) posted EBITDA of -$17554.0 for Q2 2026, down 7.19% on a QoQ basis from -$16377.0 in Q4 2025, and down 28.94% year-over-year from -$24703.3 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) EBITDA (2016 - 2026) Analysis & Trends
Acro Biomedical has reported EBITDA for 11 years, with the latest figure at -$17554.0 in Q2 2026.
- On a quarterly basis, EBITDA fell 28.94% year-over-year to -$17554.0 in Q2 2026; TTM through Jun 2026 was -$162644.0, a 295.52% decrease from a year earlier, with the FY2025 full-year figure at -$154024.0, down 305.77% from the prior year.
- EBITDA was -$17554.0 for Q2 2026 at Acro Biomedical, down from -$16377.0 in the prior quarter.
- The five-year high for EBITDA was -$8934.0 in Q1 2025, with the low at -$4.0 million in Q3 2022.
- Average EBITDA over 5 years is -$1.5 million, with a median of -$17554.0 recorded in 2026.
- The sharpest annual moves came in 2022 and 2024: EBITDA slumped 6793.35% in 2022, then soared 99.74% in 2024.
- Over 5 years, EBITDA stood at -$3.9 million in 2022, then jumped by 99.56% to -$17401.0 in 2023, then surged by 45.59% to -$9468.0 in 2024, then slumped by 72.97% to -$16377.0 in 2025, then decreased by 7.19% to -$17554.0 in 2026.
- The last three EBITDA figures came in at -$17554.0 (Q2 2026), -$16377.0 (Q4 2025), and -$115099.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.02 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 699.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 633.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 216.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 23.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 128.30 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 25.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | -17,554.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,554.00 |
| Dec 31, 2025 | -16,377.00 |
| Sep 30, 2025 | -115,099.00 |
| Jun 30, 2025 | -13,614.00 |
| Mar 31, 2025 | -8,934.00 |
| Dec 31, 2024 | -9,468.00 |
| Sep 30, 2024 | -9,106.00 |
| Jun 30, 2024 | -9,086.00 |
| Mar 31, 2024 | -10,298.00 |
| Dec 31, 2023 | -17,401.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.19 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -793,320.00 |